HMS Capital Management’s AbbVie ABBV Stock Holding History

HMS Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,000	Closed	-$92K	–	175
2018 Q4	$92K	Sell	1,000 -6,500	-87%	-$572K	0.05%	164
2018 Q3	$710K	Buy	7,500 +1,700	+29%	+$161K	0.35%	82
2018 Q2	$538K	Buy	+5,800	New	+$566K	0.3%	92
2018 Q1	–	Sell	-10,000	Closed	-$967K	–	167
2017 Q4	$967K	Buy	10,000 +1,300	+15%	+$123K	0.72%	53
2017 Q3	$774K	Hold	8,700	–	–	0.66%	51
2017 Q2	$631K	Buy	8,700 +1,100	+14%	+$74K	0.56%	64
2017 Q1	$504K	Buy	7,600 +1,400	+23%	+$88K	0.46%	78
2016 Q4	$388K	Buy	6,200 +1,200	+24%	+$73.2K	0.41%	90
2016 Q3	$315K	Buy	+5,000	New	+$324K	0.31%	97

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HMS Capital Management's ABBV Position: Q3 2019 in Review

HMS Capital Management sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 47 shares — an estimated $3K sold.

HMS Capital Management first reported a position in ABBV in Q3 2016 and held it in 11 quarters. The position peaked at $2.29M in Q4 2017. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

HMS Capital Management reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
HMS Capital Management sold 47 AbbVie shares in Q3 2019, an estimated $3K.
HMS Capital Management first reported a position in AbbVie in Q3 2016 and held it in 11 quarters.
HMS Capital Management's AbbVie position peaked at $2.29M in Q4 2017.
2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on HMS Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.